Keywords: لوسمی میلوومونوسیتی مزمن; Chronic myelomonocytic leukemia; Monocyte subsets; Flow cytometry;
مقالات ISI لوسمی میلوومونوسیتی مزمن (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لوسمی میلوومونوسیتی مزمن; Chronic myelomonocytic leukemia; Hypomethylating agents; Somatic mutations; Prognosis;
Keywords: لوسمی میلوومونوسیتی مزمن; Chronic myelomonocytic leukemia; Allogeneic hematopoietic stem cell transplantation; Donor source;
Keywords: لوسمی میلوومونوسیتی مزمن; Chronic myelomonocytic leukemia; Autoimmune diseases; Vasculitis; Immunosuppressive agents; Hypomethylating agents; Outcome
Keywords: لوسمی میلوومونوسیتی مزمن; Chronic myelomonocytic leukemia; Allogeneic hematopoietic stem cell transplantation; Graft-versus-host disease; Graft-versus-leukemia effect
Keywords: لوسمی میلوومونوسیتی مزمن; Chronic myelomonocytic leukemia; MDS; Myeloprolifrative neoplasm;
Keywords: لوسمی میلوومونوسیتی مزمن; AMC; absolute monocyte count; AML; acute myeloid leukemia; BM; bone marrow; CMML; chronic myelomonocytic leukemia; CPSS; CMML-Specific Prognostic Scoring System; ESA; erythropoiesis-stimulating agent; GFM; Groupe Français des Myélodysplasies; GVHD; graf
Keywords: لوسمی میلوومونوسیتی مزمن; Myelodysplastic syndromes; Chronic myelomonocytic leukemia; Population-based; Medical claims; Incidence; Treatment;
Keywords: لوسمی میلوومونوسیتی مزمن; Chronic myelomonocytic leukemia; Myelodysplastic syndrome; Myeloproliferative neoplasms
Keywords: لوسمی میلوومونوسیتی مزمن; α-KG; alpha-ketoglutarate; 2-HG; 2-hydroxyglutarate; 5hmC; 5-hydroxymethylcytosine; 5mC; 5-methylcytosine; AML; acute myeloid leukemia; ASXL1; additional sex combs-like 1; AZA; azacytidine; CMML; chronic myelomonocytic leukemia; DAC; decitabine; DNMT3A;
Hémophilie A acquise associée à une leucémie myélomonocytaire chronique traitée efficacement par rituximab et azacitidine
Keywords: لوسمی میلوومونوسیتی مزمن; Hémophilie acquise; Leucémie myélomonocytaire chronique; Acquired hemophilia; Chronic myelomonocytic leukemia;
Study of DNA methyl transferase 3A mutation in acute myeloid leukemic patients
Keywords: لوسمی میلوومونوسیتی مزمن; ASB-PCR; allele- specific blocker PCR; DNMT3A; DNA methyltransferase; BM; bone marrow; WBC; white blood cells; HGB; hemoglobin; CR; complete remission; ID; Induction death; OS; Overall survival; DFS; disease free survival; MPN; myeloproliferative neoplasm
CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia
Keywords: لوسمی میلوومونوسیتی مزمن; ANC; Absolute neutrophil count; AML; Acute myeloid leukemia; BL; Baseline; BM; Bone marrow; CI; Confidence intervals; CMML; Chronic myelomonocytic leukemia; CR; Complete remission; ECOG; Eastern Cooperative Oncology Group; HI; Hematologic improvement; HI-
The division of chronic myelomonocytic leukemia (CMML)-1 into CMML-0 and CMML-1 according to 2016 World Health Organization (WHO) classification has no impact in outcome in a large series of patients from the Spanish group of MDS
Keywords: لوسمی میلوومونوسیتی مزمن; Chronic myelomonocytic leukemia; CMML-0; Prognosis;
Double sword role of EZH2 in leukemia
Keywords: لوسمی میلوومونوسیتی مزمن; EZH1,2; enhancer of Zeste 1 and 2; SUZ12; suppressor of zeste 12 homolog; EED; embryonic ectoderm development; AEBP2; adipocyte enhancer-binding protein 2; RBAP46/48; retinoblastoma binding proteins 46 and 48; PRC; polycomb-repressive complex; PcG; Polyco
Nucleosidic DNA demethylating epigenetic drugs - A comprehensive review from discovery to clinic
Keywords: لوسمی میلوومونوسیتی مزمن; ALL; Acute lymphoblastic leukemia; AML; Acute myeloid leukemia; AUC; Area under the curve; AZA; 5-azacytidine; 5-aza-CdR; 2â²-deoxy-5-azacytidine; 5-aza-CR; 5-azacytidine; AZN; Azanucleosides; BED; Biologically effective dose; BSC; Best supportive care;
ETV6 and ETV7: Siblings in hematopoiesis and its disruption in disease
Keywords: لوسمی میلوومونوسیتی مزمن; ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; APL; acute promyelocytic leukemia; CID; C-terminal inhibitory domain; CML; chronic myelogenous leukemia; CMML; chronic myelomonocytic leukemia; ETS; E26-transforming specific; ETV; ETS varian
Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia
Keywords: لوسمی میلوومونوسیتی مزمن; Chronic myelomonocytic leukemia; Myeloproliferative neoplasms; Secondary acute myeloid leukemia; Allogeneic stem cell transplantation; Hypomethylating agents
Patients With Therapy-Related CMML Have Shorter Median Overall Survival Than Those With De Novo CMML: Mayo Clinic Long-Term Follow-Up Experience
Keywords: لوسمی میلوومونوسیتی مزمن; Chronic myelomonocytic leukemia; Hypomethylation; Leukemic transformation; Survival; Treatment-related
Transformation of the Clinical Management of CMML Patients Through In-Depth Molecular Characterization
Keywords: لوسمی میلوومونوسیتی مزمن; ASXL1; Chronic myelomonocytic leukemia; Hypomethylating agent; Next-generation sequencing; TET2;
DNMT3A R882 mutations in patients with cytogenetically normal acute myeloid leukemia and myelodysplastic syndrome
Keywords: لوسمی میلوومونوسیتی مزمن; AML; acute myeloid leukemia; BMA; bone marrow aspiration; CD; cluster of differentiation; CI; confidence interval; CMML; chronic myelomonocytic leukemia; CN; cytogenetically normal; CR; complete remission; DFS; disease free survival; DNA; desoxypentosenuc
The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemia
Keywords: لوسمی میلوومونوسیتی مزمن; Chronic myelomonocytic leukemia; Myeloproliferative neoplasms; SRSF2 mutation; JAK2 mutation; Bone marrow biopsy
Azacitidine in CMML: Matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival
Keywords: لوسمی میلوومونوسیتی مزمن; Matched-pair analysis; CMML; Chronic myelomonocytic leukemia; Azacitidine; Austrian Azacitidine Registry;
A role for miR-142-3p in colony-stimulating factor 1-induced monocyte differentiation into macrophages
Keywords: لوسمی میلوومونوسیتی مزمن; cAMP; cyclic 3â²5â²-adenosine monophosphate; CCNT2; cyclin T2; CMML; chronic myelomonocytic leukemia; CSF1; colony-stimulating factor 1; CUX1; cut-like homeobox 1; EGR2; early growth response 2; GFI-1; growth factor independent-1; KLF4; Krüppel-like fa
Chronic myelomonocytic leukemia: Myelodysplastic or myeloproliferative?
Keywords: لوسمی میلوومونوسیتی مزمن; chronic myelomonocytic leukemia; prognostic score; gene mutations; ASXL1 gene mutation; demethylating agents
Incidence and survival of chronic myelomonocytic leukemia in Girona (Spain): A population-based study, 1993-2007
Keywords: لوسمی میلوومونوسیتی مزمن; Chronic myelomonocytic leukemia; Incidence rate; Relative and observed survival; Population-based cancer registry;
Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature
Keywords: لوسمی میلوومونوسیتی مزمن; Chronic myelomonocytic leukemia; Leukemia cutis; Cutaneous manifestation; Prediction of prognosis
Application of vitamin D and derivatives in hematological malignancies
Keywords: لوسمی میلوومونوسیتی مزمن; MDS; myelodysplastic syndrome (preleukemia); AML; acute myelogenous leukemia; CML; chronic myelogenous leukemia; CMML; chronic myelomonocytic leukemia; NHL; non-Hodgkin's lymphoma; Vitamin D; Hematological malignancies; Intracellular kinases; Multiple m
Chromatin-modifying agents in anti-cancer therapy
Keywords: لوسمی میلوومونوسیتی مزمن; Epigenetic inhibitors; HDAC; DNMT; Anti-cancer therapy; Clinical trials; Combinatory treatments; AML; acute myeloid leukemia; AZA; 5-azacytidine; CMA; chromatin-modifying agent; CML; chronic myeloid leukemia; CMML; chronic myelomonocytic leukemia; CTCL; c
Cytopenia, Dysplasia, and Monocytosis: A Precursor To Chronic Myelomonocytic Leukemia or a Distinct Subgroup? Case Reports and Review of Literature
Keywords: لوسمی میلوومونوسیتی مزمن; Chronic myelomonocytic leukemia; Monocytosis; Myelodysplasia; Myeloproliferative/myelodysplastic; WHO classification
The role of hematopoietic cell transplantation as therapy for myelodysplasia
Keywords: لوسمی میلوومونوسیتی مزمن; myelodysplastic syndrome; hematopoietic cell transplantation; chronic myelomonocytic leukemia; IPPS;
Myelodysplastic/myeloproliferative neoplasms
Keywords: لوسمی میلوومونوسیتی مزمن; Myelodysplastic/myeloproliferative neoplasms; Chronic myelomonocytic leukemia; Atypical chronic myeloid leukemia; BCR-ABL1 negative; Myelodysplastic/myeloproliferative neoplasm; Unclassifiable MDS/MPN; WHO Classification;
Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML)
Keywords: لوسمی میلوومونوسیتی مزمن; Chronic myelomonocytic leukemia; Decitabine; Epigenetics;
Janus kinase 2 V617F mutation is detectable in spleen of patients with chronic myeloproliferative diseases suggesting a malignant nature of splenic extramedullary hematopoiesis
Keywords: لوسمی میلوومونوسیتی مزمن; JAK2; Spleen; Extramedullary hematopoiesis; Chronic myeloproliferative disorders; Chronic myelomonocytic leukemia
Atypical Myeloproliferative Disorders: Diagnosis and Management
Keywords: لوسمی میلوومونوسیتی مزمن; AML; acute myeloid leukemia; ASCT; allogeneic stem cell transplantation; CEL; chronic eosinophilic leukemia; CMD; chronic myeloid disorders; CML; chronic myeloid leukemia; CMML; chronic myelomonocytic leukemia; CNL; chronic neutrophilic leukemia; EMS; 8p1
Biology of Platelet-Derived Growth Factor and Its Involvement in Disease
Keywords: لوسمی میلوومونوسیتی مزمن; bFGF; basic fibroblast growth factor; CMML; chronic myelomonocytic leukemia; DFPS; dermatofibrosarcoma protuberans; EC; endothelial cell; EGF; epidermal growth factor; FIP1L1; Fip1-like 1; FS; fibrosarcomatous; GIST; gastrointestinal stromal tumor; HES; h
Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined
Keywords: لوسمی میلوومونوسیتی مزمن; chronic myelomonocytic leukemia; chronic neutrophilic leukemia; WHO classification
The Myelodysplastic Syndromes: Diagnosis and Treatment
Keywords: لوسمی میلوومونوسیتی مزمن; AA; aplastic anemia; ALG; antilymphocyte globulin; AML; acute myelogenous leukemia; APL; acute promyelocytic leukemia; ATG; antithymocyte globulin; ATRA; all-trans-retinoic acid; CALGB; Cancer and Leukemia Group B; CML; chronic myelogenous leukemia; CMML;
Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia
Keywords: لوسمی میلوومونوسیتی مزمن; Chronic myelomonocytic leukemia; Allogeneic transplantation; Relapse-free survival; Comorbid conditions;
Blood Eosinophilia: A New Paradigm in Disease Classification, Diagnosis, and Treatment
Keywords: لوسمی میلوومونوسیتی مزمن; AEC; absolute eosinophil count; CEL; chronic eosinophilic leukemia; CML; chronic myeloid leukemia; CMML; chronic myelomonocytic leukemia; FGFR1; fibroblast growth factor receptor 1; FISH; fluorescence in situ hybridization; HES; hypereosinophilic syndrome
The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia
Keywords: لوسمی میلوومونوسیتی مزمن; AML; acute myeloid leukemia; CMML; chronic myelomonocytic leukemia; FAB; French-American-British; FISH; fluorescent in situ hybridization; G6PD; glucose-6-phosphate dehydrogenase; HUMARA; human androgen receptor; IDS; iduronate sulphatase; ISCN; Inter
The JAK2V617F Tyrosine Kinase Mutation in Myeloproliferative Disorders: Status Report and Immediate Implications for Disease Classification and Diagnosis
Keywords: لوسمی میلوومونوسیتی مزمن; AML; acute myeloid leukemia; ATP; adenosine triphosphate; CMD; chronic myeloid disorders; CML; chronic myeloid leukemia; CMML; chronic myelomonocytic leukemia; CNL; chronic neutrophilic leukemia; CPTK; cytoplasmic PTK; EEC; endogenous erythroid colony; Ep
Immunophenotyping of Myelodysplasia
Keywords: لوسمی میلوومونوسیتی مزمن; Myelodysplastic syndrome; Immunophenotype; flow cytometry; WHO classification; FAB classification; MDS; Myelodysplastic syndromes; FAB; French-American British classification; WHO; World Health Organization; RA; Refractory Anemia; RARS; Refractory Anemia
Genetic Testing in the Myelodysplastic Syndromes: Molecular Insights Into Hematologic Diversity
Keywords: لوسمی میلوومونوسیتی مزمن; AA; all normal; AML; acute myeloid leukemia; AN; abnormal-normal; APL; acute promyelocytic leukemia; CDR; commonly deleted region; CGH; comparative genomic hybridization; CML; chronic myeloid leukemia; CMML; chronic myelomonocytic leukemia; CMML-Eos; CMML